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A b s t r a c t  
Film forming capacity of a polymeric combination consisted of HPMC/CMC was investigated for fast 
dissolvable oral films (FDOFs) of an anxiolytic agent. Other non-film forming components were 
cross-povidone as disintegrant, and polyethylene glycol 400/ sorbitol in the ratio (1:1) as plasticizer, 
citric acid as saliva stimulating agent. Buspirone hydrochloride was selected as low dose anxiolytic 
agent with less than 5% oral bioavailability. Solvent casted films were physically evaluated for 
thickness, drug content, surface pH, swelling, disintegration and in vitro drug release. Mechanical 
properties of film viz. % elongation, tensile strength, Young modulus and elongation at break were 
determined using TXT texture analyzer. Drug loaded film (2.0ï2.0 cm2 size, average weight 60-70 
mg) had average thickness in the range of 100-300 μm. Higher HPMC/CMC ratios resulted in lower 
folding endurance in films (100 turnings), shorter disintegration time (10 sec) and simulated swelling 
time of 15sec whereas films produced at lower HPMC/CMC ratios had affected film characteristics 
conversely. Mechanical properties of film were found to relate the plasticizer ratio. Folding 
endurance and tensile strength of the films prepared at higher PEG 400/sorbitol ratios, showed 
comparatively higher values than film prepared at lower ratio. It had also been determined that 
higher ratios of PEG400/sorbitol were of shorter disintegration time. No drug-exicipient interaction 
was observed from characterization studies conducted on films using FTIR and DSC methods. Films 
were stable at 30μ0.5 ÀC; 60μ5% RH.  In vitro drug release showed that BH was released from film 
within ten minutes.  It can be inferred that polymeric blend HPMC/CMC can be employed as fast 
dissolving oral film of BH for immediate release.   
Keywords: Fast dissolvable oral film (FDOF), Oral film, Buspirone Hydrochloride, HPMC/CMC, 
Plasticizer 
Introduction 
Wide acceptance and competitive dominance of oral solid dosage 
form can be ascribed as the cumulative advantages offered by two 
biopharmaceutical parameters, i.e. selection of route of 
administration and dosage form. Oral ingestion is the most 
amicable, non invasive and highly preferred for systemic availability 
of drug as it offers several advantages e.g. ease of administration, 
minimal discomfort and avoidance of certain issues e.g. sterility. 
Similarly, solid dosage form has more benefit-risk ratio, improved 
patient compliance, precise control over dose delivery, enhanced 
drug stability etc.  However oral solid dosage forms have certain 
limitations like difficulty in swallowing, sufficient fluid intake, 
unacceptability among pediatric and geriatric population associated 
with fear of chocking of dosage form [1-2]. Moreover, the efficacy 
of orally administered solid dosage form is significantly hampered 
due to pre-systemic metabolism may result in poor absorption of 
drug [3].   
Clinical effectiveness of new immediate release (IR) systems is 
well evident over conventional products. Among these systems, 
mouth dissolving films, oral patches and wafers has been shown 
more efficacious use of drug. Fast-dissolving oral films (FDOF) are 
the safe and clinically more effective than conventional dosage 
form [4]. Usefulness of FDOF has been investigated in certain 
chronic diseases like e.g. depression, emesis [5-7].  FDOFs allow 
taste masking, facilitating quick disintegration or dissolution in 
saliva and can be swallowed without intake of water [8]. However 
its mechanism is yet to be established however it has been 
proposed that drug released is itself absorbed from mouth cavity. 
FDOFs synonymously called as oral strip technology (OST) or 
mouth dissolving films, fast disintegrating films used by non-
prescription OTC medication.  Solvent casting, molten state 
blending, spraying and spreading are few techniques employed in 
the fabrication of FDOF [9-10]. 
Buspirone hydrochloride is a low dose, HT2-receptor antagonist, 
indicated for generalized anxiety disorder [11-12]. It has fair 
palatability and has high aqueous solubility, its structure is shown 
in figure 1. Low bioavailability (less than 5%) of BH is due to its 
extensive first pass metabolism following oral absorption [13].  
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A very few and limited number of film forming substances have 
been explored in the development of FDOFs. Pullulan, a natural 
polysaccharide obtained from sucrose fermentation in fungal 
strains leuconostoc mesentroid, have been widely explored as film 
former in FDOF.  Although, film forming potential of pullulan is well 
appreciated for mechanical and physical properties however issues 
on economical aspects has been raised [14]. Film forming capacity 
of maltodextrin has also been undertaken however more 
dissolution time is the major constraint. Therefore, exploration of 
new polymeric film formers would be needed and their usages 
were already in pharmaceutical exicipient. Film formation 
characteristics of HPMC had been investigated in oral strip 
technology [15-17]. More recently, nanoparticles of BCS class II 
drug was embedded in HPMC based oral films and it resulted in 
significant improvement in dissolution characteristic of drug [18]. 
Moreover HPMC showed film formation in combination with PVA 
and the developed film from polymeric combination exhibited good 
film formation which can hold sufficient mechanical strength [19].  
CMC has been shown to produce rapid disintegration in aqueous 
based film coating and comparable to PVA [20].  
The present investigation aims to explore film formation capacity of 
HPMC/ CMC blend for fabrication of FDOFs of BH using solvent 
casting method. The effect of plasticizer on mechanical properties 
of FDOF was evaluated.  
Materials and Methods 
Hydroxypropylmethylcellulose (E5, viscosity grade; 5mPas) and 
sodium carboxymethylcellulose (low viscosity grade) were kindly 
provided by Signet Chemical Corporation, Mumbai, India. Cross 
povidone, sorbitol, polyethylene glycol 400 (PEG 400) and citric 
acid were procured from SD fine chemicals (P) Ltd, Mumbai, India. 
Buspirone hydrochloride (BH) was obtained from Sigma.  All other 
chemicals and reagents used in this study were of analytical grade 
and used as received without any attempt to further purify the 
same.  
Fabrication of films  
Drug loaded HPMC/CMC films were prepared using solvent 
casting method. In brief, aqueous polymeric solution was prepared 
by dissolving specified quantity of polymers in distilled water, and 
was mixed under stirring for two hours with specified quantities of 
plasticizer and disintegrant in table 1. In another container, 
aqueous solution (0.5ml) containing drug and saliva stimulant 
agent was dissolved. Both solutions were stirred for two hours and 
allowed to stand overnight under vacuum and made free from 
entrapped air. Solution was spread uniformly with the help of 
spreader on polyvinyl tile placed over flat surface avoid rinsing. It 
was overnight dried at ambient temperature. Films of desired size 
was cut with the help of sharp knife, packed and stored in an air 
tight, light resistant container.  
Characterization of Films 
FTIR 
FT Infrared spectra of drug loaded and placebo films were 
analyzed at frequencies 400-4000 cm1 using Shimadzu, FTIR 
Spectroscope 8002. Dried films were placed vertically in sample 
holder assembly of the instrument directly and the spectrum was 
recorded whereas spectrum of drug was recorded using standard 
KBr pellet method. 
DSC 
Thermal characterization of film was ascertained by differential 
scanning calorimetry using Perkin Elmer, Calorimeter US.  Film 
sample (approx 20 mg) crippled in sealed aluminum pan were 
placed into sample holder and scanned at heating rate 5ĈC/min in 
nitrogen environment. Different thermal events were recorded in 
the temperature range of 50 to 350 ĈC with calculation of heat of 
fusion. 
Physical Evaluation of Film 
Dimension Measurment 
An average thickness of three films was measured. Thickness was 
measured at six different points from each film using digital 
coordinate measuring machine, Mitutoyo, Japan. Least count was 
0.01m.  
Folding Endurance  
Folding endurance was determined manually using simple method 
consists of folding at the vertical axis of film repeatedly. Number of 
folds required to break the film into two halves is counted as folding 
endurance.  
Drug Content 
Six samples were cut accurately equivalent area of 2ï2cm2 from 
each batch of film and were dissolved in 0.1N HCl (10.0 ml) of 
volumetric container. Resulting solution was sonicated for half an 
hour and filtered through membrane filter.  Absorbance was 
determined at λmax of 235.0 nm using double beam UV/Vis 
spectrometer model, Shimadzu, 1800. Drug content was calculated 
from standard curve drawn between known concentrations of drug 
vs. absorbance of solution.  
Surface Ph  
Aqueous solution of films was diluted and pH of solution was 
determined by pH meter.  
Disintegration Time 
Disintegration of film was determined in phosphate buffer pH 7.0 
using disintegration test apparatus. The time required (in seconds) 
to disintegrate the film was noted till mass of film was dispersed 
uniformly in the phosphate buffer pH 7.0 containing water soluble 
dye.  
Swelling Time Simulation  
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Time required to completely swell the film was determined by 
swelling time simulation method. A small plastic mesh frame 
(3.0ï3.0 cm2) was placed in a petri plate (internal diameter is 6.5 
cm) containing 1.0 ml of water maintained at 37ĈC. Film was placed 
on the mesh frame previously dipped into the water and the time 
required to wet the film was noted (in seconds). Simulated swelling 
time corresponds to the time taken by the film to disintegrate under 
simulated conditions when films were kept over the tongue. 
In Vitro Drug Release  
In vitro drug release from films was determined at 37μ0.5 ĈC at 50 
rpm using 100 ml of 0.1N HCl as a dissolution medium (n=3) in 
USP XXIV type-2 apparatus (Electrolab, TDT-06T, India). Samples 
(5.0ml) were withdrawn from from dissolution medium at 
predetermined intervals at 0.5, 1, 2, 4, 8, 10 and 15min.  Equal 
volume of fresh medium of identical temperature was replaced in 
dissolution vessel. Samples were filtered through a (0.45μm) 
membrane filter, followed suitable dilution and analyzed 
spectrophotometrically at λmax 235.0nm. Amount of dissolved drug 
was calculated from standard curve drawn between absorbance of 
known concentrations of drug.  
Texture Analysis of film 
Texture properties of the films were evaluated using TA.XT Plus, 
Texture Analyzer, Stable Microsystem, UK.  Texture properties of 
films were determined using attachments TA-96B: tensile grip 
fixture (grip distance 30mm; and grip displacement rate (0.01mm/ 
sec) at 5N load cell.  Following mechanical properties of each film 
sample were determined in triplicate. 
% Elongation  
Percentage elongation of films was calculated by dividing the 
extension of original length of film to original length of the film.      
% Elongation of film = (Extension of film length / original length of 
film) ï 100 
Tensile Strength  
Tensile strength of film was calculated from the applied load tends 
to break the film dividing its original cross- sectional area. The 
result is expressed in g/ cm2 and reported to three significant 
figures. 
Tensile strength= (Applied load at which film break/ width ï 
thickness of film) ï 100  
Elastic Modulus 
The slope of linear portion of force-displacement upward curve was 
measure of elastic modulus of film. Its units is in kg mm-1  
Elastic Modulus of film = Linear force applied on film / 
displacement of film 
Elongation At Break 
The area under force-displacement upward curve was the measure 
of tensile energy at break. 
Stability of Film 
Dynamic Vapor Sorption  
Dynamic vapor sorption studies of film was assessed by placing 
films at controlled humidity conditions maintained at 40, 50, 60, 70 
and 75 μ5% RH prepared by saturated salt solutions in humidity 
desiccators at 25ĈC. Films (2ï2 cm2) were warped in the aluminum 
foils and placed in humidity containers and the change in weight of 
FDOFs after a month period of storage was determined.   
Assay 
Films were subjected to storage at 25 μ0.5 ĈC, 60 μ5% RH and 
assayed for BH after a month.  
 
Figure 1: Structure of Buspirone hydrochloride (8-[4-(4-pyrimidin-2-
ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione)  
 
Table 1: Composition of different drug loaded film formulations 
  
 Ingredient              F1        F2       F3      F4      F5       F6       F7     F8      F9       F10     F11      F12               
HPMC E-15 (mg)      350       350     350     350     350      350    400    400     400     400      400     400 
CMC (mg)                   25      50        100     25       50        100     25      50      100       25       50      100 
Citric acid (mg)           20       20         20      20       20        20       20       20       20       20        20       20 
Sorbitol (mg)              20       20        20       40       40        40       20      20      20        40       40       40 
PEG 400 (mg)            20       30        50       20       30       50       20        30     50        20       30       50 
Crospovidone (mg)        20        20        20       20       20       20       20       20      20        20       20       20  
BH     (mg)                     40        40       40        40        40       40      40       40      40        40        40      40 
HPMC/CMC ratio          14         7     3.5        14        7         3.5     14        7        3.5      14       7       3.5  
Sorbitol/PEG ratio        1.0        0.6       0.4       2.0      1.3       0.8     1.0      0.6      0.4       2.0      1.3    0.8 
     
BH= Buspirone hydrochloride; 
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Results and Discussion 
Film forming capacity of polymeric mixture consisting of HPMC / 
CMC as well as film plasticizing property of PEG400/sorbitol was 
investigated. Fast dissolvable film of buspirone hydrochloride was 
prepared at different combinations of HPMC/CMC using solvent 
casting method and physical and mechanical properties of the 
developed films were assessed. Films prepared from HPMC alone 
were reported to have good mechanical properties of film with 
variation in film disintegration was found to depend on disintegrant 
used [21]. Carboxymethylcellulose has shown good disintegration 
properties in buccal as well as conventional tablets and has been 
employed in aqueous based film coating. Incorporation of CMC in 
polymers film formers e. g. HPMC might alter their physico-
mechanical properties of films. Composition of drug loaded films 
showing quantities of film formers, plasticizers, disintegrants and 
saliva stimulating agent are given in table 1. Several preliminary 
trials were conducted to fix the amount of disintegrating agent in 
film.  Several preliminary studies showed that quick disintegration 
of film (20secs) was achieved when fixed quantity of disintegrant 
(20mg) was added to film. The aim of present study was to 
investigate film forming capacity of HPMC/CMC and to evaluate 
the physical and mechanical properties of BH loaded FDOF at 
different levels of plasticizer (sorbitol/PEG400). Films were visually 
inspected for integrity, sign of cracks or layering on the surface of 
films and evaluated for thickness, uniformity of drug content and 
film weight, folding endurance, disintegration time and simulated 
time of swelling. 
Evaluation of film characteristics   
Films prepared at different polymeric combinations of HPMC/CMC 
and plasticizers ratio were evaluated for average weight, thickness, 
folding endurances of films as shown in table 2. Variation in drug 
content, weight of film and film thickness was corresponded to 
viscosity of polymeric film formers.  Folding endurance of film is a 
rough qualitative measure of mechanical properties of film was 
related amount of film former, plasticizer added in film. Films 
prepared at selected ratios of film formers and plasticizers, did not 
show any sign of break or crack in films and found to be 
unbreakable upto 100 to 300 folds. It is indicated from the results 
that the films were rapidly disintegrable and hold sufficient 
mechanical strength against transportation and handling. 
 
 
Table 2: Evaluation of physical parameters, texture and stability characteristics of different film formulations 
                  F1         F2      F3   F4     F5      F6     F7    F8  F9     F10      F11          F12 
PHYSICAL CHARACTERISTICS 
Film thickness* (μm)             100         103      110       121     119      122      115     109     108       126         135        115 
Average weight*** (mg)               62           65       63          64    62  62        64       68       66         64           61          65
Drug content** (mg/cm2)                     0.97        0.98     0.99     0.95       0.96      0.94     0.93    0.90    0.97       0.90      0.90       0.98
Surface pH                6.8         6.8        6.9      6.9   6.9  6.8     6.8      6.9      6.9        6.9         6.8        6.9 
Disintegration time** (sec)               8μ2         8μ1       9μ1      10μ2     10μ3     10μ2    11μ2   11μ3   12μ2    12μ1      14μ2      14μ3
Swelling time simulation**              15μ1      15μ2      15μ2     17μ2   17μ2 20μ1   20μ1   20μ2   17μ 1   25μ2      20μ1     17μ2
Mean dissolution time ǂ (min)              3μ2        4μ2        5μ2       9μ2    10μ1    6μ1      4μ3      5μ2   10μ1     13μ2      13μ2      9μ2  
Folding endurance (%)              100         108        130      200      210       230       204     210     158        320       351       298
TEXTURE ANALYSIS 
Elongation (%)                          0.75       0.85       1.52     2.5  2.7   3.0       2.59     2.75       2.15       3.4       3.7        3.2  
Breaking force (g)                                  71.9      100.5      274.2   380.1    404  472       285      410        304        480      540       415
Energy at break (g.mm ï10-2)                1.58        1.79      7.901    13.58   15.24   18.10   18.15   16.33   8.52       19.10    22.46     15.40
Young modulus (kg/mm)                        0.22       0.23        2.82     3.12    3.15       3.75      3.16     3.08     2.92       3.22     4.03       3.18
STABILITY PARAMETERS 
Film stability¶ (weight %)                         2.1         2.1        2.1       2.8        2.8        2.8        2.5        2.6       2.1        3.0        3.5          2.5          
Drug assay (%)                   99.7      99.5       99.7      99.6      99.6     99.6      99.5      99.5     99.4      99.5      99.1        99.5
* mean of ten measurements; ** mean of six determinations;  means of three readings; *** size of 2.0ï2.0 cm2 ; ¶  at 50% RH at 25C   
 
Effect of polymer ratio  
Film formation capacity of HPMC E 50 is well known and has been 
used in aqueous based film coating in tablets and sustained 
release products.  Thermo-mechanical properties of HPMC based 
films have been investigated and were found to depend upon 
specific polymer grade, type and quantity of non-film former 
ingredients added to film and method employed in its preparation 
[22].  In the present study, thickness of films was increased at 
lower HPMC/CMC ratio (Comparison of F7-F9 vs. F1-F3). During 
fabrication of films, it has been determined that increasing 
proportion of CMC in film former was resulted in higher viscosity of 
polymeric solution.  Thickness of film obtained from solvent casting 
method depends on the viscosity of polymeric solution and 
produced comparatively less flexible films as shown in Figure 2.  
Films prepared at low HPMC/CMC ratio, had lower mechanical 
strength and were easily breakable as these films could not have 
much flexibility, low tensile strength and lesser energy at break as 
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observed in figure 3. Consequently films were easily disintegrable 
showed much faster drug release from films upon dissolution [23].  
At higher HPMC content in polymeric blend, thickness of films was 
reduced due to lower viscosity of polymeric solution.  Higher 
HPMC/CMC ratios produced more flexible films with increased 
mechanical strength as determined from percentage elongation, 
tensile strength and energy required to break. Conversely such 
films showed much lower disintegration and swelling time. 
Difference in mechanical properties had been observed in films 
made from HPMC modulated by adding amount of CMC. Variation 
in film properties may be proposed to relate with polymeric 
entanglement of CMC with HPMC.   Similar observations in 
physical and mechanical properties of FDOF were obtained when 
(F2-F5) were compared with (F10-12).  
 
 
Figure 2: Force-time plot of representative formulations showing flexibility of film with respect to extension of films with time (F1, F3, F4 and F11) 
 
 
Figure 3: Area under the curve obtained from force-displacement plot of different representative film formulations (F1, F3, F4 and F11) (AUC of 
F3 =0.079; F11=0.2246; F1=0.01585; F4=0.135 kg. mm) 
  
Effect of plasticizer ratio  
Pronounced variation in films texture has been found to relate with 
amount of plasticizers incorporated in films rather than amount of 
films formers [24]. It has been shown that increasing amount of 
plasticizer produced more flexible films and modifies the texture of 
films possibly due to ease in polymeric chain movements [25]. 
However incorporation of excessive quantity in films (PEG 600) 
could produce limiting effect on the physico- mechanical properties 
of HPMC based films [26]. Increasing amount of plasticizer would 
be resulted in lower tensile strength of film, thereby produce quick 
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the plasticizing effect of PEG 400 alone was modified using 
combination of sorbitol in the ratio (1:1). Films contained larger 
proportion of sorbitol as plasticizer at fixed level of film former (F1-
F3) vs. (F4-F6) gave suffice mechanical strength to film as shown 
in table 2. It indicates form the results that incorporation of sorbitol 
as plasticizer to PEG 400 conferred more flexibility to films than 
PEG 400 alone. Plasticization property of sorbitol has been used in 
film coating of tablets. However, film prepared at larger 
HPMC/CMC ratio, increasing amount of sorbitol (F9-F12) 
decreased the mechanical strength and texture properties as 
observed in F12 batch. Area under the force displacement curve of 
F4 batch was much higher than F1 indicates better film texture as it 
may be result from increased amount of plasticizer (figure 3). 
Above results showed that the films took more energy to fracture 
were comparatively tough and disintegrated comparatively slower 
and took much large dissolution time as shown in figure 4 and 5. 
Films were comparatively more elastics if they had higher YoungÊs 
modulus [27].  
 
 
Figure 4:  Time taken to release (t 90%) from film formulations (F1 to F12) where t 90% is the 90% drug was released. 
 
Figure: 5 In-vitro drug release from various film formulations (F1to F12) 
 
Characterization of films 
Films were characterized by FTIR spectroscopic method and were 
represented in figure 6. FTIR characterization revealed that films 
showed strong absorption bands at 2800 cm-1 resulted from 
aliphatic C-H group, stretching vibration at 1250-1330 cm-1 for 
aromatic amine and stretching vibration at 1722 cm-1 was due to 
C=O (ketone) groups and stretching at 1250 cm-1 for aliphatic C-N 
groups. FTIR spectra of FDOFs have had identical group 
frequencies of BH. Thermal characterization was films performed 
using DSC studies and were represented in figure 7. DSC 
thermogram showed that no extra thermal event other than one 
melting endothermic at 200ĈC which corresponds to melting point 
of drug. On the basis of spectral and thermal characterization 
studies on films, no interaction between drug and the exicipients in 
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Figure 6: FTIR spectroscopic characterization of various film formulations (F1 toF12); drug sample (BH); placebo film (F11)  
 
 
Figure 7: DSC thermogram of various film formulations (F1 to F12); pure drug (BH) and placebo film (F11)  
 
Disintegration & In vitro drug release 
In vitro drug release studies and disintegration test of films were 
carried out in phosphate buffer at pH 6.8 and its results were 
shown in figure 5.  Mean disintegration time of films was found to 
be less than 14 seconds whereas its corresponding in vitro 
dissolution time was 600 seconds. Large dissolution time was 
attributed to entanglement of drug in film base which mainly 
comprised of polymeric and plasticizing component. These 
components retard the drug release entrapped in its base. Though 
quick disintegration of film was take place at higher HPMC/ CMC 
ratios [23]. However the CMC has been used as and aid to 
disintegrant It resulted in enhancement of dissolution times for 
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films. Time required to completely moisten and swell the film was 
also lowered in case of film with low HPMC/ CMC ratios.  
Stability studies 
Vapor sorption studies were carried out on films at different relative 
humidity levels and its effect on weight of FDOFs was given in 
table 2 and graphically represented in fig 8. No significant changes 
in the weight of films were observed when it was subjected for 
storage at controlled humidity conditions maintained. All FDOFs 
formulations at these conditions were stable below 60%RH in 
integrity and strength irrespective of HPMC/CMC ratio [28]. 
However at low HPMC/ CMC ratio, moisture sorption was 
comparatively large. Low moisture sorption had been observed at 
higher HPMC /CMC ratio. No significant change in assay of BH in 
the FDOF was observed after a month. Dynamic vapour sorption 
studies also revealed that films containing higher amount of CMC 
adsorb more water at humidity level above 60% RH. It would have 
been resulted in stickiness tendency of the films. 
 
Figure: 8 Vapor sorption studied conducted on film formulations at different humidity levels at 50, 60, 65 and 75% RH for a month and its effect 
on weight of films. 
Conclusion 
Film forming potential of a polymeric combination consisted of 
HPMC/CMC using solvent casting method was explored for fast 
dissolvable film of buspirone hydrochloride. FDOFs exhibited 
plausible features in fabricated films like  texture and mechanical 
strength, physical and stability characteristics upto 65%RH. Quick 
disintegration of the FDOF within seconds can be related with 
lower HPMC/CMC ratio and PEG400/sorbitol ratio however it took 
ten folds higher time for drug release. No interaction between drug 
and exicipients was occurred in FDOFs. Film texture was found to 
be more related with the nature and quantity of plasticizer 
incorporated whereas thickness, disintegration and dissolution 
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